Yes, it is true, Jim Cramer loves Apple so much that he now uses his mantra of "own Apple, don't trade it" as an ice breaker in conversation. Not because he is socially inept, but because it is just that important.
He told the winning jockey Victor Espinoza on the Triple Crown winner American Pharaoh to own it this weekend. He even passed the love of Apple on to Phillie Phanatic, the costumed mascot of the Phillies, right before he threw the first pitch at Citizens Bank stadium recently.
"I feel a powerful need to get people to stop trading certain stocks and just own them as long as the fundamentals of the underlying company continue to do well," the "Mad Money" host said. (Tweet This)
Monday was an important day for Apple, as it brought their Worldwide Developers Conference, where investors learned more about what Apple has up its sleeve. It featured more than 100 technical sessions, at least 1,000 Apple engineers and unveiled plans to launch a music streaming service on June 30.
Cramer considers Apple to be both a vessel and an ecosystem. It's a vessel that draws smart people who want to write programs. It is an ecosystem because Cramer enjoys linking Apple apps with his new phone; he loves that he can respond to inquiries on his watch without looking like a jerk by taking out his phone.
"I know the focus right now is on Apple and music. I'm not as enthused by that. In fact, I don't care at all," Cramer said. (Tweet This)
People tend to get agitated when Cramer calls a stock a cult stock. But on days like Monday, when the Dow struggles to hold gains for the year, it is important to point out that the cult stocks all did well.
A cult stock is not a dirty four-letter word; on the contrary, it can be an opportunity!
Cramer has always defined a cult stock as one that is very hard to value because it does not trade on traditional valuation metrics. So, instead of the stock flying based on earnings, a cult stock like Netflix trades based on a sexy press release or a new television show.
"When stocks fly into orbit, breaking free from all traditional valuation restraints, I have a hard time telling you to buy them. That's because with the underpinnings of fundamental analysis, I run the risk of making a mistake that could really hurt any potential buyers," the "Mad Money" host said.
Besides Netflix, other names that are the most obvious cult stocks are Amazon, Shake Shack and Tesla. Often, Cramer finds that these stocks have a "someday" factor to them. Investors believe that someday they are going to make a ton of money, and they want to be there when it happens.
Another stock that is about to break into being a cult classic, is Ambarella. Cramer was totally confused by this stock when it reported better than expected numbers and then sold off. What the heck happened?
"The truth is I have no choice but to say it, because it's doing much better than I expected. I just have to own that I'm way late to the first move and need to count on another wave of products—the door phone—coming out without much competition," Cramer added.
At a time when the restaurant group has taken a beating on Wall Street, there is one stock that continues to roar. Zoe's Kitchen has been on fire, up 10 percent since it reported on Thursday.
This stock has been a wild one, as it peaked at $40 last October and then fell down to $20 when the lockup on insider trading expired. However, it has been steadily climbing its way back, as it is one of the fastest growing regional to national restaurant stories in America.
Is it time to take a bite of the stock? To find out, Cramer sat down with Zoe's Kitchen CEO Kevin Miles.
"We can grow the business, we can control the culture, we can teach and educate our team around living Mediterranean and living the lifestyle of the Mediterranean," Miles said.
At a time when Cramer keeps telling investors to get involved with all things health care, he introduced investors to a company that is a bit further up on the health care food chain as a high quality life sciences company.
Thermo Fisher Scientific is the top player in the life sciences tools business. It provides lab customers with everything needed to conduct real science, offering a substantial diagnostics division, an environmental and food safety business and a genomics platform.
"Think of Thermo Fisher as an arms dealer for biotech and pharmaceutical companies," Cramer said.
The company even managed to report a very strong quarter back in April, even though it was hit hard by the strength of the dollar. Could currency impact the potential upside to the stock? To find out, Cramer spoke with Thermo Fisher Scientific CEO Marc Casper.
"From a currency perspective, I think all of the multi-nationals are facing it, but we are navigating it effectively. In fact, this year we should have 4 to 6 percent earnings growth despite some currency headwinds," Casper said.
As Cramer has said many times recently, we are in a no-win environment when it comes to economic growth. Either the economy will continue to slow, or the Fed will raise interest rates and slam the brakes on commerce in this country in order to make the superfreakin' dollar stronger than it already is.
Unfortunately, one of these two scenarios is very likely to become reality, but that does not mean all stocks need to take a nose dive as a result. A low-growth environment can be good news for companies with consistent growth, as investors will soon flock to them.
"I think we are going to see huge piles of money pour into these consistent, secular growth cohorts that tend to dramatically outperform the rest of the market during a slowdown," the "Mad Money" host said. (Tweet This)
With this in mind, Cramer's favorite secular growth theme right now is the health-care cost-containment plays. Health care is one group that remains consistent, as people still will not cut back even when they feel less wealthy. The cost containment plays are some of the fastest growers because health-care costs have become such a huge problem in America.
This week, Cramer will focus on his three favorite wholesale drug distribution companies, which play a huge role in containing health-care costs. Cardinal Health is a very acquisitive company that acts as both a wholesale supplier of drugs and medical supplies, including everything from surgical apparel to gloves to fluid-management products.
"If the company can keep making these small but meaningful acquisitions over time, then I could see the stock ultimately trading much higher. Plus, I think Cardinal could potentially be an attractive takeover candidate for its larger and better capitalized competitor McKesson," Cramer added.
In the Lightning Round, Cramer gave his take on a few caller favorite stocks:
PNC Financial Services Group: "You're right to buy it. Here's the problem—it just hit a 52-week high today. I think the market is headed down for a couple of days, but that's a great place to be."
Royal Caribbean Cruises: "I like Royal but I have to tell you, I saw Carnival Corp last week and I am quite taken by Carnival. I prefer you to be in that one."
Correction: This article has been updated to reflect Cramer's mantra to hold Apple, not trade it.